ISSN : 3023-7505
  • Home
  • About The Journal
  • Editorial Board
  • Instructions for Authors
  • Contact
Current Issue
Ahead Of Print
Archive
Search
Most Popular
Download Articles Read Articles
Automated Perimetry
Carbonic Anhydrase Inhibitors
Intra Ocular Lens Power Calculation and Optic Biometry...
Visual Field Defects in Glaucoma
Visual Field Defect and Retinal Nerve Fiber Layer Defect in a Case of Optic Nerve Head Drusen...
Current Minimal Invasive Angle Procedures Without Implants for the Treatment of Glaucoma...
Intra Ocular Lens Power Calculation and Optic Biometry...
Automated Perimetry
Carbonic Anhydrase Inhibitors
Visual Field Defect and Retinal Nerve Fiber Layer Defect in a Case of Optic Nerve Head Drusen...
PureSee Kesintisiz Yüksek Kalitede Görüş
TJ-CEO 2024 , Vol 19 , Num 2
Abstract Free Full Text Similar Articles Mail to Author
Treatment outcomes in eyes with postkeratoplasty glaucoma
Fatma Sema Akkan Aydogmus1, Oya Tekeli2, Emine Esra Karaca3, Ozlem Evren Kemer4, Cenk Zeki Fikret3, Dilay Ozek3
1MD, Ophthalmology of Department, Ankara Bilkent City Hospital, Ankara, Türkiye
2MD, Prof., Ophthalmology of Department, Faculty of Medicine, Ankara University, Ankara, Türkiye
3MD, Assoc Prof., Ophthalmology of Department, Ankara Bilkent City Hospital, Ankara, Türkiye
4MD, Prof.,Ophthalmology of Department, Ankara Bilkent City Hospital, Ankara, Türkiye
DOI : 10.37844/TJ-CEO.2024.19.10 Purpose: To evaluate the clinical outcomes, surgical indications, results of medical, surgical and micropulse transscleral cyclophotocoagulation (MP-TSCPC) treatment in patients with postkeratoplasty glaucoma.

Materials and Methods: Fifty-six eyes of 53 patients with glaucoma who had undergone keratoplasty were included in the study. Demographic and clinical characteristics, medical and surgical (either trabeculectomy or MP-TSCPC) treatment results were evaluated retrospectively.

Results: The mean age of patients was 52.8 ± 19.1 years (9- 84). The most common indication for keratoplasty was bullous keratopathy in 15 eyes (26.8 %). The mean follow-up period was 29.3 ± 36.7 months. Glaucoma control was achieved by medical treatment in 46 (82.1%), MP-TSCPC in 5 (8.9%), trabeculectomy in 3(5.4%), and combined therapy in 2 (3.6%) of eyes. For MP-TSCPC cases the mean pre-treatment IOP was 28.5 mmHg and the mean post-treatment IOP was 14.6 mmHg. With % 40 reduction, the best results were taken in MP-TSCPC group. No patients had hipotony or graft failure.

Conclusions: Glaucoma control can be achieved by medical, surgical and MP-TSCPC treatment in eyes with postkeratoplasty. MPTSCPC is a safe and effective IOP lowering method in these eyes. Keywords : Glaucoma, keratoplasty, micropulse laser, micropulse transscleral cyclophotocoagulation, postkeratoplasty glaucoma

PureSee Kesintisiz Yüksek Kalitede Görüş
Home
About The Journal
Editorial Board
Instructions for Authors
Contact